1460778441-ee610e67-8e57-4d74-836b-2218e693486a

1. A surgical drape assembly, comprising:
a sterile pump assembly including a non-sterile driving mechanism coupled to the pump assembly by a sterile pump drive cable,
a surgical drape having at least one aperture dimensioned to allow the sterile pump drive cable to pass therethrough so as to isolate the non-sterile driving mechanism from the sterile pump assembly located within the surgical field; and
a panel structure coupled to said surgical drape adapted to support at least one of said sterile pump assembly and said non-sterile driving mechanism.
2. The surgical drape assembly of claim 1 and further, wherein said panel structure is further adapted to support a display for displaying information to surgical personnel.
3. The surgical drape assembly of claim 1 and further, wherein said panel structure is further adapted to support at least one of a suction port coupled to a suction source and a pressure port coupled to a pressure source.
4. The surgical drape assembly of claim 1 and further, wherein the panel structure is adapted to support a gas port coupled to a least one of an oxygen source and a carbon dioxide source.
5. The surgical drape assembly of claim 1 and further, wherein said surgical drape is constructed from a generally transparent material.
6. The surgical drape assembly of claim 1 and further, wherein said panel structure is dimensioned to be positioned between the head and neck region of the patient and the torso region of the patient.
7. The surgical drape assembly of claim 1 and further, wherein said panel structure is adapted to support at least one of an oxygenator and a fluid reservoir forming part of a cardiopulmonary bypass circuit.
8. A method of isolating a sterile blood pump disposed within the sterile surgical field from a non-sterile motor disposed outside the sterile surgical field, comprising the steps of:
(1) positioning a surgical drape and panel assembly such that a panel structure is positioned between the head and neck region of the patient and the torso region of the patient;
(2) coupling said sterile blood pump to the side of the panel structure facing the torso region of the patient such that the sterile blood pump is disposed within the sterile surgical field; and
(3) coupling said non-sterile motor to the side of the panel structure facing the head and neck region of the patient such that the motor is disposed outside the sterile surgical field.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A foam comprising:
a continuous liquid phase selected from the group consisting of alcohols, aldehydes, ketones, esters, ethers, amines, amides, hydrocarbons, halocarbons, natural rubber resin, synthetic rubber resin, fluoroelastomer, thermosetting resins, and mixtures thereof comprising a plurality of surface-modified organic molecules dispersed in a continuous phase, said organic molecules comprising fullerenes; and
a dispersed gas phase dispersed in said continuous phase, wherein the foam is free of surfactant.
2. The foam of claim 1 wherein the surface-modified organic molecules comprise alkyl surface groups.
3. The foam of claim 2 wherein the alkyl groups are at least C3.
4. The foam of claim 2 wherein the alkyl groups are not greater than C30.
5. The foam of claim 2 wherein the alkyl groups range from C3 to C22.
6. The foam of claim 2 wherein the alkyl groups range from C3 to C18.
7. The foam of claim 2 wherein the alkyl groups range from C3 to C12.
8. The foam of claim 2 wherein the alkyl groups are C3 to C8 and any combination or integer therebetween.
9. The foam of claim 1 wherein the organic molecules are C60, C70, C82, or C84 fullerenes, or combinations thereof.
10. The foam of claim 1 wherein the dispersed phase is selected from the group consisting of nitrogen, argon, oxygen, carbon dioxide, nitrous oxide, water, air, helium, sulfur hexafluoride, aliphatic hydrocarbons, aliphatic alcohols, fully and partially halogenated aliphatic hydrocarbons, and combinations of any of these.
11. The foam of claim 1 wherein the organic molecules are a mixture of fullerenes and dendrimers.
12. The foam of claim 1 further comprising surface-modified inorganic nanoparticles.
13. The foam of claim 1 wherein the continuous phase further comprises water.
14. A foam composition comprising:
a liquid continuous phase selected from the group consisting of alcohols, aldehydes, ketones, esters, ethers, amines, amides, hydrocarbons, halocarbons, natural rubber resin, synthetic rubber resin, fluoroelastomer, thermosetting resins, and mixtures thereof;
surface-modified organic molecules disposed in the continuous phase, said organic molecules comprising fullerenes; and
a foaming agent.
15. The foam composition of claim 14 wherein the surface-modified organic molecules comprise alkyl surface groups.
16. The foam composition of claim 15 wherein the alkyl groups are at least C3.
17. The foam composition of claim 15 wherein the alkyl groups are not greater than C30.
18. The foam composition of claim 15 wherein the alkyl groups range from C3 to C22.
19. The foam composition of claim 15 wherein the alkyl groups range from C3 to C18.
20. The foam composition of claim 15 wherein the alkyl groups range from C3 to C12.
21. The foam composition of claim 15 wherein the alkyl groups are C3 to C8 and any combination or integer therebetween.
22. The foam composition of claim 15 further comprising surface-modified inorganic nanoparticles.
23. The foam composition of claim 14 wherein the organic molecules are fullerenes and dendrimers.
24. The foam of claim 23 further comprising surface-modified inorganic nanoparticles.
25. The foam composition of claim 14 wherein the foam composition is disposed within a container.
26. The foam composition of claim 14 wherein the foam is free of surfactant.
27. The foam composition of claim 14 wherein the organic molecules are C60, C70, C82, or C84 fullerenes.
28. The foam composition of claim 14 wherein the foaming agent is selected from the group consisting of nitrogen, argon, oxygen, carbon dioxide, nitrous oxide, water, air, helium, sulfur hexafluoride, aliphatic hydrocarbons, aliphatic alcohols, fully and partially halogenated aliphatic hydrocarbons, and combinations of any of these.
29. The foam composition of claim 14 wherein the continuous phase further comprises water.
30. A foam comprising:
a continuous liquid phase comprising a plurality of organic polymeric micro spheres dispersed in a continuous phase comprising water; and
a dispersed gas phase dispersed in said continuous phase, wherein the organic polymeric microspheres have an average particle size of at least 20 nm and not more than 60 nm.
31. The foam of claim 30 wherein the organic polymeric microspheres comprise polystyrene.
32. A foam composition comprising:
a continuous liquid phase comprising a plurality of organic polymeric microspheres dispersed in a continuous phase comprising water wherein the organic polymeric microspheres have an average particle size of at least 20 nm and not more than 60 nm; and
a foaming agent.
33. The foam composition of claim 32 wherein the foaming agent is selected from the group consisting of nitrogen, argon, oxygen, carbon dioxide, nitrous oxide, water, air, helium, sulfur hexafluoride, aliphatic hydrocarbons, aliphatic alcohols, fully and partially halogenated aliphatic hydrocarbons, and combinations of any of these.
34. The foam composition of claim 32 further comprising surface-modified inorganic nanoparticles.